Publications by authors named "Marcia Moss"

Claim this Profile
L
Leveraging the ADAM10 prodomain for selective inhibition to enhance recovery after myocardial infarction.
Erik Klapproth, Johanna Marks, Patrick Diaba-Nuhoho, Sören Grell, Paul Leubauer, Marcia L Moss

Br J Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells.
Michael Gorry, Toshie Yoneyama, Lazar Vujanovic, Marcia L Moss, Michelle A Garlin

J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.
Marcia L Moss, Dmitry Minond

Mediators Inflamm· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker.
Toshie Yoneyama, Michael Gorry, Andrea Sobo-Vujanovic, Yan Lin, Lazar Vujanovic, Marcia L Moss

J Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates.
Toshie Yoneyama, Michael Gorry, Miles A Miller, Autumn Gaither-Davis, Yan Lin, Marcia L Moss

J Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent substrates for ADAM15 useful for assaying and high throughput screening.
Marcia L Moss, Miles A Miller, Nikola Vujanovic, Toshie Yoneyama, Fred H Rasmussen

Anal Biochem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved fluorescent substrate for assaying soluble and membrane-associated ADAM family member activities.
Marcia L Moss, Dmitriy Minond, Toshie Yoneyama, Hinrich P Hansen, Nikola Vujanovic

Anal Biochem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro.
Hinrich P Hansen, Ahmad Trad, Maria Dams, Paola Zigrino, Marcia Moss

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
Miles A Miller, Marcia L Moss, Gary Powell, Robert Petrovich, Lori Edwards

Sci Rep· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A colorimetric-based amplification system for proteinases including MMP2 and ADAM8.
Marcia L Moss, Garrit Koller, Jörg W Bartsch, Sinja Rakow, Uwe Schlomann

Anal Biochem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The function of the milk-clotting enzymes bovine and camel chymosin studied by a fluorescence resonance energy transfer assay.
Jesper Langholm Jensen, Jonas Jacobsen, Marcia L Moss, Fred Rasmussen, Karsten Bruun Qvist

J Dairy Sci· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM8 as a drug target in pancreatic cancer.
Uwe Schlomann, Garrit Koller, Catharina Conrad, Taheera Ferdous, Panagiota Golfi, Marcia L Moss

Nat Commun· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EphrinA/EphA-induced ectodomain shedding of neural cell adhesion molecule regulates growth cone repulsion through ADAM10 metalloprotease.
Leann H Brennaman, Marcia L Moss, Patricia F Maness

J Neurochem· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of fluorescent metalloproteinase substrates for cancer detection.
Roopali Roy, David Zurakowski, Susan Pories, Marcia L Moss, Marsha A Moses

Clin Biochem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
Marcia L Moss, Gary Powell, Miles A Miller, Lori Edwards, Bin Qi

J Biol Chem· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.
Miles A Miller, Layla Barkal, Karen Jeng, Andreas Herrlich, Marcia Moss

Integr Biol (Camb)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.
Christoph Garbers, Nathalie Jänner, Athena Chalaris, Marcia L Moss, Doreen M Floss

J Biol Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection.
Jörg W Bartsch, Dirk Wildeboer, Garrit Koller, Silvia Naus, Andrea Rittger, Marcia L Moss

J Neurosci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor.
Florian Schelter, Julia Kobuch, Marcia L Moss, J David Becherer, Paolo M Comoglio

J Biol Chem· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent substrates useful as high-throughput screening tools for ADAM9.
Marcia L Moss, Fred H Rasmussen, Raphael Nudelman, Peter J Dempsey, Jason Williams

Comb Chem High Throughput Screen· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAMs: targets for drug discovery.
Marcia L Moss

Curr Pharm Des· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM10 as a therapeutic target for cancer and inflammation.
Howard C Crawford, Peter J Dempsey, Gordon Brown, Liana Adam, Marcia L Moss

Curr Pharm Des· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17.
Cary W Esselens, Jordi Malapeira, Núria Colomé, Marcia Moss, Francesc Canals

Biol Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis.
Marcia L Moss, Liora Sklair-Tavron, Raphael Nudelman

Nat Clin Pract Rheumatol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM10 as a target for anti-cancer therapy.
Marcia L Moss, Alexander Stoeck, Wenbo Yan, Peter J Dempsey

Curr Pharm Biotechnol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis